This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Licata, L.
Right arrow Articles by Frosco, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Licata, L.
Right arrow Articles by Frosco, M.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, May 1997, 950-955, Vol 41, No. 5
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Comparison of the postantibiotic and postantibiotic sub-MIC effects of levofloxacin and ciprofloxacin on Staphylococcus aureus and Streptococcus pneumoniae

L Licata, CE Smith, RM Goldschmidt, JF Barrett and M Frosco
Department of Microbiology, The R. W. Johnson Pharmaceutical Research Institute, Raritan, New Jersey 08869, USA.

The postantibiotic subminimum inhibitory concentration effect (PA SME) may simulate in vivo drug exposure more accurately than the postantibiotic effect (PAE) since subinhibitory concentrations of drug persist between antibiotic dosings. In this study, we compared the PAEs and PA SMEs of levofloxacin and ciprofloxacin for clinical isolates of fluoroquinolone-susceptible Staphylococcus aureus and Streptococcus pneumoniae. At two times the MIC, PAEs of levofloxacin were an average of 0.6 h longer than the PAEs obtained for ciprofloxacin for methicillin-susceptible and methicillin-resistant S. aureus strains. The PAEs of levofloxacin and ciprofloxacin ranged from 1.8 to 3.1 and 1.1 to 2.4 h, respectively. Continued exposure of the methicillin- resistant strain to 1/16, 1/8, and 1/4 the MIC resulted in PA SMEs of 6.5, 15.3, and >22.3 h, respectively, for levofloxacin and 3.8, 8.0, and 12.3 h, respectively, for ciprofloxacin. For isolates of S. pneumoniae, at two times the MIC of both fluoroquinolones, the average PAEs of levofloxacin and ciprofloxacin were equivalent: 1.3 h for the penicillin-susceptible isolate and 0.6 h for the penicillin-resistant isolate. Continued exposure of the penicillin-susceptible S. pneumoniae strain to 1/16, 1/8, and 1/4 the MIC resulted in average PA SMEs of 1.0, 1.4, and 2.8 h, respectively, for levofloxacin and 1.8, 2.0, and 2.5 h, respectively, for ciprofloxacin. Continued exposure of penicillin-resistant S. pneumoniae to 1/16, 1/8, and 1/4 the MIC of the same fluoroquinolones resulted in average PA SMEs of 0.6, 1.1, and 2.9 h, respectively, for levofloxacin and 0.6, 1.1, and 1.5 h, respectively, for ciprofloxacin. The PA SMEs observed demonstrate the superior activity of levofloxacin against methicillin-susceptible or methicillin-resistant S. aureus. Although PAEs were similar for the penicillin-susceptible and penicillin-resistant S. pneumoniae strains, the PA SME of levofloxacin at one-fourth the MIC was longer for penicillin-resistant S. pneumoniae.


This article has been cited by other articles:

  • Hoshi, S., Kikuchi, K., Sasaki, T., Sotozono, C., Kinoshita, S., Hiramatsu, K. (2008). Postantibiotic Effects and Bactericidal Activities of Levofloxacin and Gatifloxacin at Concentrations Simulating Those of Topical Ophthalmic Administration against Fluoroquinolone-Resistant and Fluoroquinolone-Sensitive Methicillin-Resistant Staphylococcus aureus Strains. Antimicrob. Agents Chemother. 52: 2970-2973 [Abstract] [Full Text]  
  • Noreddin, A. M., Haynes, V. L., Zhanel, G. G. (2005). Pharmacokinetics and Pharmacodynamics of the New Quinolones. Journal of Pharmacy Practice 18: 432-443 [Abstract]  
  • Athamna, A., Athamna, M., Medlej, B., Bast, D. J., Rubinstein, E. (2004). In vitro post-antibiotic effect of fluoroquinolones, macrolides, {beta}-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis. J Antimicrob Chemother 53: 609-615 [Abstract] [Full Text]  
  • Odenholt, I., Lowdin, E., Cars, O. (2003). Postantibiotic, Postantibiotic Sub-MIC, and Subinhibitory Effects of PGE-9509924, Ciprofloxacin, and Levofloxacin. Antimicrob. Agents Chemother. 47: 3352-3356 [Abstract] [Full Text]  
  • Pankuch, G. A., Jacobs, M. R., Appelbaum, P. C. (2003). Postantibiotic Effects of Daptomycin against 14 Staphylococcal and Pneumococcal Clinical Isolates. Antimicrob. Agents Chemother. 47: 3012-3014 [Abstract] [Full Text]  
  • Odenholt, I., Cars, T., Lowdin, E. (2000). Pharmacodynamic studies of trovafloxacin and grepafloxacin in vitro against Gram-positive and Gram-negative bacteria. J Antimicrob Chemother 46: 35-43 [Abstract] [Full Text]  
  • Gander, S., Finch, R. (2000). The effects of exposure at constant (1 h) or exponentially decreasing concentrations of quinupristin/dalfopristin on biofilms of Gram-positive bacteria. J Antimicrob Chemother 46: 61-67 [Abstract] [Full Text]  
  • Davies, T. A., Ednie, L. M., Hoellman, D. M., Pankuch, G. A., Jacobs, M. R., Appelbaum, P. C. (2000). Antipneumococcal Activity of ABT-773 Compared to Those of 10 Other Agents. Antimicrob. Agents Chemother. 44: 1894-1899 [Abstract] [Full Text]  
  • Davies, T. A., Kelly, L. M., Hoellman, D. B., Ednie, L. M., Clark, C. L., Bajaksouzian, S., Jacobs, M. R., Appelbaum, P. C. (2000). Activities and Postantibiotic Effects of Gemifloxacin Compared to Those of 11 Other Agents against Haemophilus influenzae and Moraxella catarrhalis. Antimicrob. Agents Chemother. 44: 633-639 [Abstract] [Full Text]  
  • Davies, T. A., Kelly, L. M., Pankuch, G. A., Credito, K. L., Jacobs, M. R., Appelbaum, P. C. (2000). Antipneumococcal Activities of Gemifloxacin Compared to Those of Nine Other Agents. Antimicrob. Agents Chemother. 44: 304-310 [Abstract] [Full Text]  
  • Spangler, S. K., Bajaksouzian, S., Jacobs, M. R., Appelbaum, P. C. (2000). Postantibiotic Effects of Grepafloxacin Compared to Those of Five Other Agents against 12 Gram-Positive and -Negative Bacteria. Antimicrob. Agents Chemother. 44: 186-189 [Abstract] [Full Text]  
  • Pendland, S. L., Diaz-Linares, M., Garey, K. W., Woodward, J. G., Ryu, S., Danziger, L. H. (1999). Bactericidal Activity and Postantibiotic Effect of Levofloxacin against Anaerobes. Antimicrob. Agents Chemother. 43: 2547-2549 [Abstract] [Full Text]  
  • Hikida, M., Itahashi, K., Igarashi, A., Shiba, T., Kitamura, M. (1999). In Vitro Antibacterial Activity of LJC 11,036, an Active Metabolite of L-084, a New Oral Carbapenem Antibiotic with Potent Antipneumococcal Activity. Antimicrob. Agents Chemother. 43: 2010-2016 [Abstract] [Full Text]  
  • Lister, P. D., Sanders, C. C. (1999). Pharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneumoniae. J Antimicrob Chemother 43: 79-86 [Abstract] [Full Text]  
  • Spangler, S. K., Lin, G., Jacobs, M. R., Appelbaum, P. C. (1998). Postantibiotic Effect and Postantibiotic Sub-MIC Effect of Levofloxacin Compared to Those of Ofloxacin, Ciprofloxacin, Erythromycin, Azithromycin, and Clarithromycin against 20 Pneumococci. Antimicrob. Agents Chemother. 42: 1253-1255 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»